(PDF) Can We Use Sorafenib Targeted Therapy for Advanced

Can We Use Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma (HCC) Child Pugh B

HPB - United Kingdom

doi 10.1016/j.hpb.2016.02.530

Full Text

Abstract

Available in full text

Categories

Gastroenterology

Date

April 1, 2016

Authors

Publisher

Elsevier BV

Related search

Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of Rationing in the United Kingdom.

Journal of Clinical Oncology

Cancer Research

English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

Multidisciplinary

English

Evaluation of Tolerability and Efficacy of Irreversible Electroporation (IRE) in Treatment of Child-Pugh B (7/8) Hepatocellular Carcinoma (HCC)

Gastroenterology

English

Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Pugh B Liver Disease

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Hepatocellular Carcinoma and Sorafenib: How Can We Improve on the Current Standard of Care in Advanced Disease?

Advanced Research in Gastroenterology & Hepatology

English

Outcomes of SBRT for HCC in Patients With Child-Pugh B and C Cirrhosis

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology

English

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles

Drug Design, Development and Therapy

Pharmaceutical Science

English

Reply To: “Nomogram to Predict Surgical Hepatocellular Carcinoma With Child-Pugh B: Feasibility and Overlooked Predictors”

Journal of Hepatology

English